Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure
Authors:
- 1 October 2017
- journal article
- research article
- Published by Elsevier in JACC: Heart Failure
- Vol. 5 (10) , 724-734
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Galectin-3 in Ambulatory Patients With Heart FailureCirculation: Heart Failure, 2012
- Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic DysfunctionCirculation: Heart Failure, 2012
- Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older AdultsCirculation, 2011
- Clinician’s Guide to Cardiopulmonary Exercise Testing in AdultsCirculation, 2010
- Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary SyndromeCirculation: Cardiovascular Genetics, 2010
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureJAMA, 2009
- Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION): Design and rationaleAmerican Heart Journal, 2007
- The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion InjuryCirculation Research, 2006
- GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein ActivationCirculation Research, 2006
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005